Medicines Articles
Bristol-Myers Squibb’s ipilimumab has shown early promise for helping patients with advanced melanoma that has spread to the brain.
A first-of-its-kind prostate cancer treatment that uses the body’s immune system to fight the disease has been approved by the U.S. Food and Drug Administration.
Octapharma USA has initiated a voluntary withdrawal of all lots of Octagam (immune globulin intravenous [human] 5% liquid preparation) from the U.S. marketplace.